Why Fevertree Drinks plc is a top stock pick for 2018

Fevertree Drinks plc (LON:FEVR) appears as expensive as ever, but the firm looks to have more tricks up its sleeve.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It seems that since listing in 2014 Fevertree Drinks (LSE: FEVR) has consistently gone from strength to strength to become the £2.5bn market cap business it is today. By broadening its portfolio of premium mixers and convincing ever more bars and individuals to upgrade to its offerings, Fevertree has claimed a higher share of the UK drinks market than even the rosiest projections its IPO prospectus predicted were possible.

And although the company’s valuation of 66 times 2017 consensus earnings looks as pricey as the day it floated, I still believe Fevertree is a fantastic company and stock to own for the long haul. Much of my enthusiasm stems from the fact that the company’s co-founders still run the show, which gives me confidence that they can repeat their stunning success in the UK overseas.

And although the company continues to reliably double its UK sales period after period, there is no doubt overseas markets will become the company’s most important if it is to live up to its lofty valuation. Its announcement in December that it was ceasing its relationship with a third party distributor in North America in order to to directly control the expansion of its brand there lends credence to this theory.

To date, Fevertree has had little trouble recording consistent double-digit sales growth in North America, but growth there has been nowhere near as impressive as at home. Yet the rewards are mind-boggling if increased management attention to the huge American market can make its cola or ginger beer as popular in the US as its tonics are in the UK.

This is a lofty goal, but Fevertree’s founder-led management team, asset-light business model, superior products and fragmented competition all leave me confident that the business will continue to grow by leaps and bounds to live up to its rich valuation.

Time to be contrarian? 

A  domestic business with a more down-to-Earth valuation that also sees great potential in the US is food-to-go manufacturer Greencore (LSE: GNC). Dublin-headquartered Greencore is already the UK’s largest provider of ready made sandwiches and meals to the grocery sector and bulked up its operations Stateside last year through the $747m purchase of Peacock Foods.

This deal was transformative as it not only bulked up the company’s manufacturing facilities in the country, enabling the group to handle larger contracts for bigger customers. In addition, it opened up access to the vast US grocery market for the first time via legacy contracts with consumer goods giants such as Tyson.

The aforementioned contracts with Tyson have turned out to be a bit of a mixed blessing for Greencore though, as that company’s purchase of a rival food-to-go manufacturer has sparked fears that it will end contracts with Greencore. But with the two having co-invested in factories and having long-term contracts, there’s little fear of this happening out of the blue.

And with the business in the US growing volumes nicely and winning contracts, combined with stellar double-digit growth at home, market nervousness has made Greencore look incredibly cheap to me at 13 times forward earnings.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Greencore. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »